Completed
Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older With the G551D Mutation
NCT00909532
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +8 more
- Locations
-
- University of Alabama Birmingham, Alabama, United States
- Kaiser Permanente Medical Care Program Oakland, California, United States
- Cystic Fibrosis Research Office, Stanford University Palo Alto, California, United States
- Rady Children's Hospital San Diego, California, United States